Corrigendum to "miR-515-5p suppresses HCC migration and invasion via targeting IL6/JAK/STAT3 pathway" [Surg Oncol.
Jun-Sheng Ni1, Hao Zheng2, Yang-Liu Ou3
1Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, 200438, China; Key Laboratory of Signaling Regulation and Targeting Therapy of Hepatocellular Carcinoma (SMMU), Ministry of Education, Shanghai, 200438, China; Shanghai Key Laboratory of Hepatobiliary Tumor Biology (EHBH), Shanghai, 200438, China.
Surgical Oncology
|August 14, 2022
Abstract
No abstract available in PubMed .


